UCB makes its patient-level study data available for requesting using the Vivli Platform.
“We are delighted to welcome UCB as a member of Vivli and to work with them and
other members to securely share their studies with researchers,” said Rebecca Li, Vivli Executive Director.
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
“UCB has worked with the Vivli platform and its team as it has grown and developed and we are thrilled to be joining Vivli,” said Liz Roberts, Senior Director, Strategic Data Opportunities Policy Lead at UCB. “We look forward to working with the Vivli team as well as the other members to continue to share our data and advance scientific research.”